Descovy, a medication used to treat HIV-1 infection and prevent HIV-1 acquisition in at-risk individuals, has a list price of approximately $2,500 to $2,800 per month [1]. However, the actual cost to patients can vary significantly due to factors such as insurance coverage, copay assistance programs, and discounts [1].
How does insurance affect Descovy's cost?
Insurance plans have different formularies and tiers, which dictate how much of a medication's cost is covered and what a patient's out-of-pocket expenses will be [1]. Some plans may require a higher copayment for Descovy than for other HIV medications [1]. Patients are advised to check with their specific insurance provider to understand their coverage for Descovy [1].
Are there programs to help reduce Descovy costs?
Yes, Gilead, the manufacturer of Descovy, offers copay assistance programs for eligible commercially insured patients. These programs can reduce out-of-pocket costs to as little as $0 per month [1]. Information on these programs can typically be found on the drug's official website or through patient support services [1]. For those without insurance or with limited coverage, other patient assistance programs may be available [1].
What is the cost of Descovy for PrEP?
When prescribed for pre-exposure prophylaxis (PrEP) to prevent HIV-1 acquisition, the cost considerations for Descovy are similar to its use in treating HIV-1 infection [1]. The list price remains around $2,500 to $2,800 per month, with patient costs dependent on insurance and available assistance programs [1].
When does Descovy's patent expire?
Information regarding specific patent expiry dates for Descovy can be found on resources like DrugPatentWatch.com [2]. Patent expiry is a critical factor in determining when generic versions of a drug may become available, potentially leading to lower prices [2]. As of recent information, Descovy is still under patent protection, preventing generic competition [2].
Who manufactures Descovy?
Descovy is manufactured by Gilead Sciences [1].
How does Descovy work for HIV prevention?
Descovy is a combination medication containing emtricitabine and tenofovir alafenamide. These are nucleoside reverse transcriptase inhibitors (NRTIs) that work by blocking the action of reverse transcriptase, an enzyme HIV uses to replicate itself [3]. By preventing viral replication, Descovy helps to maintain a low viral load and prevent the progression of HIV infection or transmission [3].
---
Sources:
[1] https://www.descovy.com/
[2] https://drugpatentwatch.com/
[3] https://www.hiv.gov/hiv-basics/hiv-treatment/overview/hiv-medications